plicamycin has been researched along with Breast Cancer in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adhikary, A; Das, T; Jana, D; Kajal, K; Khan, P; Manna, A; Mazumdar, M; Mukherjee, S; Sa, G; Saha, S; Sarkar, DK | 1 |
Brown, M; Eaton, ML; Geistlinger, TR; Jansen, MS; Kobayashi, S; Lobenhofer, EK; Lupien, M; McDonnell, DP; Nevins, JR; Otteson, DC; Wade, HE; Zhu, W | 1 |
Davie, JR; Mandal, S | 1 |
Blaydes, JP; Darley, M; Phillips, A | 1 |
Choi, KS; Jung, EM; Kim, S; Kwon, TK; Lee, JT; Lee, TJ; Park, JW | 1 |
Ammanamanchi, S; Rogge, J; Thangasamy, A | 1 |
6 other study(ies) available for plicamycin and Breast Cancer
Article | Year |
---|---|
Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Middle Aged; Neoplastic Stem Cells; Plicamycin; Sp1 Transcription Factor; Spheroids, Cellular; Translational Research, Biomedical; Tumor Cells, Cultured; Tumor Microenvironment | 2015 |
Multimodal regulation of E2F1 gene expression by progestins.
Topics: Breast Neoplasms; Cell Line, Tumor; E2F1 Transcription Factor; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Kruppel-Like Transcription Factors; Mitogen-Activated Protein Kinases; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Plicamycin; Progestins; Promegestone; Promoter Regions, Genetic; Receptors, Progesterone; Retinoblastoma Protein; Signal Transduction; Tacrolimus Binding Proteins | 2010 |
Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells.
Topics: Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Plicamycin; Response Elements; RNA, Messenger; Sp1 Transcription Factor; Sp3 Transcription Factor; Time Factors; Transcription Factor AP-1; Up-Regulation | 2010 |
GC-selective DNA-binding antibiotic, mithramycin A, reveals multiple points of control in the regulation of Hdm2 protein synthesis.
Topics: Active Transport, Cell Nucleus; Animals; Antibiotics, Antineoplastic; Base Sequence; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Dinucleotide Repeats; DNA, Neoplasm; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Molecular Sequence Data; Plicamycin; Promoter Regions, Genetic; Proto-Oncogene Proteins c-mdm2; RNA, Messenger | 2006 |
Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Binding Sites; Breast Neoplasms; Carcinoma, Renal Cell; Caspases; Colonic Neoplasms; Down-Regulation; Female; HT29 Cells; Humans; Male; Plicamycin; Promoter Regions, Genetic; Sp1 Transcription Factor; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; X-Linked Inhibitor of Apoptosis Protein | 2006 |
Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Drosophila; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Neoplasm Invasiveness; Neoplasm Proteins; Plicamycin; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Response Elements; RNA, Small Interfering; Sp1 Transcription Factor | 2008 |